Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1: genes and variants
Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 is linked to 1 analyzed protein (NOTCH3). 89 DNA variants are known to cause it; 138 more are uncertain, and 1 of those already look disease-causing on computable evidence.
Last updated 2026-09-30. Research information, not medical advice.
Genes linked to Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1
NOTCH3: Neurogenic locus notch homolog protein 3
Its signaling helps maintain vascular smooth-muscle and mural-cell identity in small arteries. Pathogenic cysteine-altering variants cause CADASIL, with migraine, recurrent ischemic strokes, white-matter disease, and progressive cognitive impairment.
89 disease-causing and 138 uncertain variants in NOTCH3 are linked to Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1.
Where Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 variants cluster
- NOTCH3 EGF-like 1 (positions 40–77): 12 of 89 disease-causing changes, 8.2× more than its size predicts.
- NOTCH3 EGF-like 4 (positions 158–195): 11 of 89 disease-causing changes, 7.5× more than its size predicts.
- NOTCH3 EGF-like 3 (positions 119–156): 10 of 89 disease-causing changes, 6.9× more than its size predicts.
- NOTCH3 EGF-like 13 (positions 507–543): 6 of 89 disease-causing changes, 4.2× more than its size predicts.
- NOTCH3 EGF-like 5 (positions 197–234): 6 of 89 disease-causing changes, 4.1× more than its size predicts.
Known disease-causing variants in Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| NOTCH3 R133C | 133 | EGF-like 3 | Disease-causing (★★) |
| NOTCH3 C146Y | 146 | EGF-like 3 | Disease-causing (★★) |
| NOTCH3 C516Y | 516 | EGF-like 13 | Disease-causing (★★) |
| NOTCH3 C516F | 516 | EGF-like 13 | Disease-causing (★★) |
| NOTCH3 C65S | 65 | EGF-like 1 | Disease-causing (★★) |
| NOTCH3 C65Y | 65 | EGF-like 1 | Disease-causing (★★) |
| NOTCH3 C146R | 146 | EGF-like 3 | Disease-causing (★★) |
| NOTCH3 C174R | 174 | EGF-like 4 | Disease-causing (★★) |
| NOTCH3 C174Y | 174 | EGF-like 4 | Disease-causing (★★) |
| NOTCH3 C183R | 183 | EGF-like 4 | Disease-causing (★★) |
| NOTCH3 C428Y | 428 | EGF-like 10 | Disease-causing (★★) |
| NOTCH3 C144F | 144 | EGF-like 3 | Disease-causing (★★) |
| NOTCH3 R332C | 332 | EGF-like 8 | Disease-causing (★★) |
| NOTCH3 C511R | 511 | EGF-like 13 | Disease-causing (★★) |
| NOTCH3 C1015R | 1015 | EGF-like 26 | Disease-causing (★★) |
| NOTCH3 C43Y | 43 | EGF-like 1 | Disease-causing (★★) |
| NOTCH3 C49Y | 49 | EGF-like 1 | Disease-causing (★★) |
| NOTCH3 C49G | 49 | EGF-like 1 | Disease-causing (★★) |
| NOTCH3 C67F | 67 | EGF-like 1 | Disease-causing (★★) |
| NOTCH3 R182C | 182 | EGF-like 4 | Disease-causing (★★) |
| NOTCH3 C194F | 194 | EGF-like 4 | Disease-causing (★★) |
| NOTCH3 C224Y | 224 | EGF-like 5 | Disease-causing (★★) |
| NOTCH3 C233Y | 233 | EGF-like 5 | Disease-causing (★★) |
| NOTCH3 C251R | 251 | EGF-like 6 | Disease-causing (★★) |
| NOTCH3 R427C | 427 | EGF-like 10 | Disease-causing (★★) |
| NOTCH3 R54C | 54 | EGF-like 1 | Disease-causing (★★) |
| NOTCH3 R141C | 141 | EGF-like 3 | Disease-causing (★★) |
| NOTCH3 R153C | 153 | EGF-like 3 | Disease-causing (★★) |
| NOTCH3 C55Y | 55 | EGF-like 1 | Disease-causing (★★) |
| NOTCH3 R75P | 75 | EGF-like 1 | Disease-causing (★★) |
| NOTCH3 C82F | 82 | EGF-like 2 | Disease-causing (★★) |
| NOTCH3 R90C | 90 | EGF-like 2 | Disease-causing (★★) |
| NOTCH3 C106G | 106 | EGF-like 2 | Disease-causing (★★) |
| NOTCH3 R110C | 110 | EGF-like 2 | Disease-causing (★★) |
| NOTCH3 C117Y | 117 | EGF-like 2 | Disease-causing (★★) |
| NOTCH3 C123F | 123 | EGF-like 3 | Disease-causing (★★) |
| NOTCH3 R169C | 169 | EGF-like 4 | Disease-causing (★★) |
| NOTCH3 C206Y | 206 | EGF-like 5 | Disease-causing (★★) |
| NOTCH3 C260F | 260 | EGF-like 6 | Disease-causing (★★) |
| NOTCH3 C311F | 311 | EGF-like 7 | Disease-causing (★★) |
| NOTCH3 S396C | 396 | EGF-like 10 | Disease-causing (★★) |
| NOTCH3 C419G | 419 | EGF-like 10 | Disease-causing (★★) |
| NOTCH3 G420C | 420 | EGF-like 10 | Disease-causing (★★) |
| NOTCH3 C455F | 455 | EGF-like 11 | Disease-causing (★★) |
| NOTCH3 R532C | 532 | EGF-like 13 | Disease-causing (★★) |
| NOTCH3 C542R | 542 | EGF-like 13 | Disease-causing (★★) |
| NOTCH3 C559Y | 559 | EGF-like 14 | Disease-causing (★★) |
| NOTCH3 R607C | 607 | EGF-like 15 | Disease-causing (★★) |
| NOTCH3 R640C | 640 | EGF-like 16 | Disease-causing (★★) |
| NOTCH3 Y710C | 710 | EGF-like 18 | Disease-causing (★★) |
| NOTCH3 R985C | 985 | EGF-like 25 | Disease-causing (★★) |
| NOTCH3 C271F | 271 | EGF-like 6 | Disease-causing (★★) |
| NOTCH3 C504Y | 504 | EGF-like 12 | Disease-causing (★★) |
| NOTCH3 R558C | 558 | EGF-like 14 | Disease-causing (★★) |
| NOTCH3 C568R | 568 | EGF-like 14 | Disease-causing (★★) |
| NOTCH3 C597W | 597 | EGF-like 15 | Disease-causing (★★) |
| NOTCH3 R1031C | 1031 | EGF-like 26 | Disease-causing (★★) |
| NOTCH3 R1076C | 1076 | EGF-like 27 | Disease-causing (★★) |
| NOTCH3 R544C | 544 | Extracellular | Disease-causing (★★) |
| NOTCH3 R578C | 578 | EGF-like 14 | Disease-causing (★★) |
Showing 60 of 89.
Uncertain variants in Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 that look disease-causing
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| NOTCH3 C597S | 597 | EGF-like 15 | Conflicting reports (★) | +7: C597W at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.962 |
Which prediction tools work for Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1
How often each tool ranks a disease-causing variant above a harmless one (AUROC × 100).
- MetaLR: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 82 out of 100
- SIFT: 79 out of 100
- phyloP: 61 out of 100
Same protein, different disease
- Myofibromatosis, infantile, 2 is also caused by NOTCH3 variants; they fall mostly in different places as the Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 variants (12 disease-causing).
Diseases related to Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1
- Myofibromatosis, infantile, 2, also linked to NOTCH3
- Auditory neuropathy, also linked to NOTCH3
- Lateral meningocele syndrome, also linked to NOTCH3
- Adams-Oliver syndrome, also linked to NOTCH3
- Ischemic stroke, also linked to NOTCH3
- Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy, also linked to NOTCH3
Frequently asked questions
Which genes are linked to Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1?
In CATVariant, Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 is linked to 1 analyzed protein: NOTCH3 (Neurogenic locus notch homolog protein 3).
How many genetic variants are linked to Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1?
300 variants: 89 are classified as disease-causing (pathogenic or likely pathogenic) in ClinVar and 138 are of uncertain significance or have conflicting reports.
Which uncertain variants in Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 look disease-causing?
1 uncertain variants reach the likely-pathogenic range of the ACMG/AMP points scale on computable evidence, for example NOTCH3 C597S. These are leads for expert review, not diagnoses.
Which variant effect predictor works best for Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1?
Among tools not trained on clinical labels, CADD separates this disease's known disease-causing variants from harmless ones best (AUROC 0.82, based on 36 disease-causing and 84 harmless variants).
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from the latest public CATVariant analysis of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center